Philip (Phil) McCaw is a non-executive director of Aroa Biosurgery.
He is a resident of New Zealand, is the Founding Partner of Movac, one of New Zealand’s leading Venture Capital funds and has been appointed Chair of the New Zealand Government’s Startup Advisors’ Council, to help identify and address the opportunities and challenges facing high growth start-up businesses.
Phil led the original investment round into Aroa Biosurgery in 2008, has worked closely with the Company and has served on the Board since then.
Phil has over 20-years experience investing into New Zealand technology companies and helping to guide their growth. Phil was an early investor in Trade Me, New Zealand’s leading on-line trading community, which was sold to Fairfax in 2006. He was also an early investor into PowerByProxi, a wireless power technology spin-out from Auckland University, which was sold to Apple in 2018. Outside of Movac, Phil remains an active angel investor and maintains a personal angel investment portfolio. He is a strong advocate for the development of the entrepreneurial and early-stage investment eco-system in New Zealand and was the past Chair of the Angel Association of New Zealand; a founding investor in the Lightning Lab technology accelerator; and a founding investor in the Kiwi Landing Pad in San Francisco.
Prior to starting Movac Phil spent 10-years with Deloitte Consulting working in New Zealand and the USA. Phil has a Bachelor of Business Studies (Senior Scholar) from Massey University. Due to his relationship with ongoing substantial shareholders in Aroa Biosurgery, Phil is considered by the Board to not be an independent Director. He is a member of the Remuneration and Nomination Committee.
